American Century Companies’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,298
| Closed | -$440K | – | 2924 |
|
|
2024
Q3 | $440K | Sell |
9,298
-1,549
| -14% | -$73.3K | ﹤0.01% | 2517 |
|
|
2024
Q2 | $324K | Sell |
10,847
-36,820
| -77% | -$1.1M | ﹤0.01% | 2593 |
|
|
2024
Q1 | $1.92M | Buy |
47,667
+24,893
| +109% | +$1M | ﹤0.01% | 1902 |
|
|
2023
Q4 | $580K | Sell |
22,774
-211,784
| -90% | -$5.39M | ﹤0.01% | 2312 |
|
|
2023
Q3 | $3.26M | Buy |
234,558
+124,005
| +112% | +$1.72M | ﹤0.01% | 1499 |
|
|
2023
Q2 | $2.54M | Sell |
110,553
-4,489
| -4% | -$103K | ﹤0.01% | 1566 |
|
|
2023
Q1 | $3.4M | Buy |
115,042
+4,328
| +4% | +$128K | ﹤0.01% | 1404 |
|
|
2022
Q4 | $2.76M | Sell |
110,714
-117,496
| -51% | -$2.93M | ﹤0.01% | 1456 |
|
|
2022
Q3 | $4.97M | Buy |
228,210
+1,351
| +0.6% | +$29.4K | ﹤0.01% | 1108 |
|
|
2022
Q2 | $4.47M | Buy |
226,859
+13,899
| +7% | +$274K | ﹤0.01% | 1146 |
|
|
2022
Q1 | $9.01M | Buy |
212,960
+25,933
| +14% | +$1.1M | 0.01% | 944 |
|
|
2021
Q4 | $11.9M | Buy |
187,027
+36,281
| +24% | +$2.3M | 0.01% | 835 |
|
|
2021
Q3 | $8.86M | Buy |
150,746
+52
| +0% | +$3.06K | 0.01% | 878 |
|
|
2021
Q2 | $7.31M | Buy |
150,694
+362
| +0.2% | +$17.6K | 0.01% | 896 |
|
|
2021
Q1 | $5.84M | Sell |
150,332
-1,243
| -0.8% | -$48.3K | ﹤0.01% | 898 |
|
|
2020
Q4 | $9.4M | Sell |
151,575
-198
| -0.1% | -$12.3K | 0.01% | 776 |
|
|
2020
Q3 | $4.9M | Buy |
+151,773
| New | +$4.9M | ﹤0.01% | 806 |
|